Company / Free Cash Flow
Vanda Pharmaceuticals Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$12.4M
FY2025
5-year range
$12.4M / $63.7M
FY2021-FY2025
Trend
-60.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from -$82M in FY2016 to $64M in FY2023.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of -16.0%.
Declined from $64M to $12M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -37.1%
- 5-Year CAGR
- -16.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.0%, indicating a declining trend.
- In FY2025, free cash flow decreased 60.3% year-over-year.
- Peak free cash flow was recorded in FY2023.
- Lowest free cash flow in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.4M | -60.3% |
| FY2024 | $31.3M | -50.8% |
| FY2023 | $63.7M | +27.4% |
| FY2022 | $50.0M | +11.2% |
| FY2021 | $44.9M | +51.7% |
| FY2020 | $29.6M | +912.1% |
| FY2019 | -$3.6M | +61.7% |
| FY2018 | -$9.5M | -195.8% |
| FY2017 | $9.9M | +112.1% |
| FY2016 | -$82.3M | -107.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026